【打印本页】 【下载PDF全文】 【HTML】 查看/发表评论下载PDF阅读器关闭

←前一篇|后一篇→

过刊浏览    高级检索

本文已被:浏览 1603次   下载 1337 本文二维码信息
码上扫一扫!
人血管生成素相关蛋白2单克隆抗体的制备与鉴定
孟舒,曹江,黄盛东,秦永文
0
(上海交通大学附属新华医院心内科,上海,200092;第二军医大学长海医院心血管内科,上海,200433;长海医院胸心外科)
摘要:
目的:制备人血管生成素相关蛋白2(angiopoietin-related protein 2,ARP2)的单克隆抗体.方法:用RT-PCR方法获取人脾脏组织ARP2基因序列,构建pET32a-ARP2,经电穿孔导入大肠杆菌诱导表达,获得可溶蛋白样品和包涵体蛋白样品,回收、纯化蛋白,免疫BALB/c小鼠,采用杂交瘤技术建立产生ARP2抗杂交瘤细胞株,Western印迹鉴定.结果:获得融合蛋白的相对分子质量为570 000,与理论计算值相符,纯化后蛋白浓度>90﹪,杂交瘤细胞培养上清抗体效价为1:104,腹水抗体效价为1:107~1:108,抗体亚型为IgG2a类,Western印迹示目的蛋白相对分子质量为570 000,免疫组化显示该抗体能特异结合人ARP2.结论:制备的抗ARP2单克隆抗体可用于ARP2蛋白鉴定.
关键词:  血管生成素相关蛋白2、抗体,单克隆、杂交瘤技术
DOI:10.3724/SP.J.1008.2006.00781
投稿时间:2005-12-19修订日期:2006-04-24
基金项目:国家自然科学基金(30171029).
Preparation and identification of monoclonal antibody against angiopoietin-related protein 2
MENG Shu,CAO Jiang,HUANG Sheng-dong,QIN Yong-wen
(上海交通大学附属新华医院心内科,上海,200092;第二军医大学长海医院心血管内科,上海,200433)
Abstract:
Objective:To prepare a monoclonal antibody against human angiopoietin-related protein 2(ARP2). Methods: Human spleen ARP2 gene was obtained by RT-PCR. A pET32a-ARP2 plasmid was constructed and was incorporated into E. coli. The products were purified and were used to immunize 6-week-old BALB/c female mice. Hybridoma secreting antiARP2 monoclonal antibody was obtained by standard procedure. Mass production was carried out after specificity identification with Western blotting. Results: The fusion protein obtained by pET32a system had a relative molecular weight of about 570 000, which was in accordance with the theoretical value. The purity of the protein was more than 90% after purification. The antibody titer was 1 : 104 in the hybridoma culture supernatant and 1 : 107-10s in the ascites. The IgG2a type antibody had a relative molecular weight of about 570 000 by Western blot analysis. Immunohistochemistry method showed that the antibody bond with human ARP2. Conclusion: The prepared anti-human ARP2 monoclonal antibody in this study can be used for identification of ARP2 protein.
Key words:  angiopoietin-related protein 2  antibodies,monoclonal  hybridomas